Novel fsh glycosylation variant d3n

Details Novel fsh glycosylation variant d3n Novel fsh glycosylation variant d3n

C - Chemistry, Metallurgy

07

K

C07K 14/59 (2006.01) A61K 38/24 (2006.01) C12N 15/16 (2006.01)

Patent

CA 2633844

FSH mutant with increased glycosylation and longer half-life is described. The use of this FSH mutant for inducing folliculogenesis in human patients is also described.

L'invention concerne un mutant de FSH à glycosylation augmentée et demi-vie plus longue. L'invention concerne également l'utilisation d'un tel mutant de FSH pour induire la folliculogénèse chez des patients humains.

Affiliated with

Also associated with

Rating

Novel fsh glycosylation variant d3n does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel fsh glycosylation variant d3n, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel fsh glycosylation variant d3n will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1569981